Corrigendum: DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression.

Gong, Li-Bao; Wen, Ti; Li, Zhi; Xin, Xing; Che, Xiao-Fang; Wang, Jin; Liu, Yun-Peng; Qu, Xiu-Juan.

Gong LB; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.
Wen T; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China.
Li Z; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.
Xin X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China.
Che XF; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.
Wang J; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China.
Liu YP; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.
Qu XJ; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China.

Front Oncol ; 12: 819244, 2022.

Article en En | MEDLINE | ID: mdl-35280738